NOTE: As provided in LFC policy, this report is
intended only for use by the standing finance committees of the
legislature. The Legislative Finance Committee does not assume
responsibility for the accuracy of the information in this report when used for
other purposes.
The most recent FIR
version (in HTML & Adobe PDF formats) is available on the Legislative
Website. The Adobe PDF version includes
all attachments, whereas the HTML version does not. Previously issued FIRs and attachments may be
obtained from the LFC in
SPONSOR: |
Heaton |
DATE TYPED: |
|
HB |
402/aHBIC/aHAFC/aSPAC |
||
SHORT TITLE: |
Prescription Drugs Waiver for Seniors |
SB |
|
||||
|
ANALYST: |
Weber |
|||||
APPROPRIATION
Appropriation
Contained |
Estimated
Additional Impact |
Recurring or
Non-Rec |
Fund Affected |
||
FY03 |
FY04 |
FY03 |
FY04 |
|
|
|
|
|
$12,700 |
Recurring |
General
Fund |
|
|
|
|
|
|
(Parenthesis
( ) Indicate Expenditure Decreases)
REVENUE
Estimated Revenue |
Subsequent Years Impact |
Recurring or
Non-Rec |
Fund Affected |
|
FY03 |
FY04 |
|
|
|
$37,700.0 |
|
|
Recurring |
Federal
Funds |
|
|
|
|
|
(Parenthesis ( ) Indicate Revenue Decreases)
SB
391 is almost identical
Responses
Received From
Human
Services Department
Agency
on Aging
SUMMARY
Synopsis of SPAC
Amendment
The Senate Public Affairs Committee made two
amendments, both striking items in previous amendments.
On page 2, line 6, after "seniors"
strike the remainder of the line, strike all of lines 7 and 8 and on line 9, strike "for elderly".,
3. On page 1, line 17,
after "1." insert "MEDICAID".
4. On page 1, line 17,
strike "WAIVER".
5. On page 1, line 20,
strike "waiver" and insert in lieu thereof "prescription
drug".
These
are all changes which do not change the original intent or potential result of
the original bill.
Synopsis
of HAFC Amendment
The House Appropriations and Finance Committee
amendments generally make minor language improvements. The exceptions are that the emergency clause
and appropriation are eliminated.
Synopsis of HBIC
Amendment
The House Business and Industry Committee amendment
clarifies participant eligibility. On
page 1, line 21, after “to” strike the remainder of the line and strike lines
22 through 25 in their entirety, and on the insert:
“persons whose incomes are less then one hundred
eighty-five percent of the federal poverty level and who:
Synopsis
of Original Bill
HB
402 appropriates $150,000 from the General Fund for expenditure in Fiscal Years
2003 and 2004 to the Human Services Department to create a Medicaid Waiver
program that would provide prescription drugs to seniors over the age of
sixty-five with incomes of no more than one hundred eighty-five percent of the
federal poverty level (FPL) and to persons who meet the state’s fiscal eligibility
criteria for the Developmental Disabilities (DD) Waiver and the Disabled and
Elderly (D&E) Waiver. HB 402
contains an emergency clause.
The
bill also provides for cost-sharing provisions, to the extent practicable, so
as to minimize state general fund expenditures.
Significant
Issues
Medical Assistance
Division (MAD) coordinated the response with the State Agency on Aging. It would appear that the intent of this bill
is to provide prescription drugs to individuals over age sixty-five, up to 185%
federal poverty level (FPL), currently $1,366/month and to certain disabled
individuals up to 225% FPL, currently $1,656/month.
Section 1 identifies
those persons other than seniors to be served as those who meet the state’s fiscal eligibility criteria for the DD
and D&E Waiver programs. The fiscal
eligibility for those waiver programs is approximately 225% FPL. This section does not specify that they have
to meet other eligibility criteria for the waiver programs, such as level of
care.
Section 2 identifies
those persons eligible, other than seniors, as persons “eligible for services under the state’s Medicaid waiver programs
for…” This would require that the
individuals also meet all other eligibility criteria, including level of care.
Many seniors over the
age of sixty-five, as well as those on the DD and D&E Waivers, are Medicaid
recipients and already covered for prescription drugs. This would provide prescription drugs for
those individuals on the DD and D&E waiting lists.
Some individuals whom
would be covered by this bill have prescription drug coverage under a private
plan. The bill does not address this
“crowd out” issue.
The Center for
Medicare and Medicaid Services (CMS) has a model state demonstration template,
“Pharmacy Plus,” which allows states, through an 1115 Demonstration waiver, to
expand Medicaid coverage prescription drugs to Medicare beneficiaries and other
individuals with incomes up to 200% FPL.
Individuals must not otherwise be eligible for the full Medicaid package.
This bill would allow
coverage to individuals above 200% FPL.
The review and approval process by CMS would certainly take longer than
if the population addressed was under 200% FPL.
This waiver would also cover persons in two categories of fiscal
eligibility: those under 185% FPL and
those under 225% FPL. It is unclear
whether CMS would approve a waiver with two categories of fiscal eligibility.
FISCAL IMPLICATIONS
The appropriation of
$150.0 contained in this bill is a non-recurring expense to the General Fund.
Any unexpended or unencumbered balance remaining at the end of Fiscal Year 2004
shall revert to the General Fund.
HSD states the
bill instructs the department to use cost-sharing to minimize state general
fund expenditures. The age 65 and over
Based on existing
blended utilization data for these populations, an average of five prescriptions
monthly at a cost of $40 each would be expected, or $50.4 million
annually. Under Medicaid federal
participation rates, the state’s share of this amount would be slightly more
than $12.7 million. If a $5 co-pay were
utilized the state share drops to $11.0 million. In the absence of a “crowd out” feature from
private insurance, there is no reason all of the eligible individuals would not
use prescriptions through the program with resultant higher costs.
TECHNICAL ISSUES
The description of eligible populations in
Sections 1 and 2 are not the same. It is
assumed the definition in Section 2 is correct, but the discrepancy must be
addressed through amendment.
MW/njw:sb